BALA CYNWYD, PA / ACCESSWIRE / November 6, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Wright Medical Group N.V. ("Wright Medical" or the "Company") (WMGI) for possible breaches of fiduciary duty and other violations of federal and state law in connection with proposed acquisition of the Company by Stryker Corporation (SYK). Under the terms of the agreement, Wright Medical shareholders will receive only $30.75 for each share of Wright Medical common stock owned.
The investigation concerns whether the Wright Medical Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Stryker Corporation is underpaying for the Company. The transaction may undervalue the Company and result in a loss for Wright Medical shareholders. For example, the consideration is below the 52-week high of $32.86 and at least one analyst following the Company has set a price target at $40.00.
If you own shares of Wright Medical stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/wright-medical-group-n-v-nasdaq-wmgi/, or calling toll free 877-534-2590.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE: Brodsky & Smith, LLC
View source version on accesswire.com: